NCT02483806

Brief Summary

One lung ventilation (OLV) is essential during thoracic surgery. During OLV, intrapulmonary shunt can be increased resulting hypoxemia. Wang et al measured intrapulmonary shunt by transesophageal echocardiography. Although OLV technique had been advanced so far, hypoxemia during OLV reaches about 10% in spite of inspired oxygen fraction 100%. Applying PEEP(Positive End-expiratory Pressure) at dependent lung and CPAP at non-dependent lung can mitigate the hypoxemia. Above all, PEEP can be easily applicable. However, there are controversial studies whether it is supportive or not. In this prospective, cross-over study, the investigators are planning to investigate the effects of PEEP on intrapulmonary shunt, oxygenation and cardiac function as well.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Jun 2015

Shorter than P25 for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 29, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

June 29, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2016

Completed
Last Updated

December 28, 2017

Status Verified

December 1, 2017

Enrollment Period

11 months

First QC Date

June 19, 2015

Last Update Submit

December 26, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • the effect of differential PEEP (0, 5, 10 cmH2O) by PaO2(P/F ratio)

    20 minutes after each PEEP apply

  • Cardiac function

    cardiac function : Tei index

    20 minutes after each PEEP apply

Study Arms (3)

PEEP 0 cmH2O

EXPERIMENTAL

PEEP 0 cmH2O (zero end expiratory pressure, ZEEP)

Procedure: PEEP

PEEP 5 cmH2O

EXPERIMENTAL
Procedure: PEEP

EEP 10 cmH2O

EXPERIMENTAL
Procedure: PEEP

Interventions

PEEPPROCEDURE

After induction of anesthesia, including insertion of TEE probe, change position from supine to lateral position. Measure ABGA and cardiac indices for the baseline value. Apply each PEEP (0, 5, 10 cmH2O) serially at the random order. 6 sequences (0-\>5-\>10, 0-\>10-\>5, 5-\>10-\>0, 5-\>0-\>10, 10-\>5-\>0, 10-\>0-\>5) are equally applied to 6 patients (total 6x6=36 patients) who agreed to this study. Measure ABGA and cardiac indices after 20 min at each step of peep apply(3 times).

Also known as: Positive EndExpiratory Pressure breathing(PEEP)
EEP 10 cmH2OPEEP 0 cmH2OPEEP 5 cmH2O

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • scheduled for VATS lobectomy
  • ≤ age ≤ 80
  • American Society of Anaesthesiologists(ASA) physical status classification I\~III

You may not qualify if:

  • American Society of Anaesthesiologists(ASA) physical status classification IV
  • NYHA class III\~IV
  • Severe obstructive lung disease and/or restrictive lung disease patients
  • those with end-organ diseases (i.e. heart failure, respiratory failure, hepatic failure, renal failure)
  • arrhythmia
  • esophageal varix
  • pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine

Seoul, 120-752, South Korea

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2015

First Posted

June 29, 2015

Study Start

June 29, 2015

Primary Completion

May 25, 2016

Study Completion

May 25, 2016

Last Updated

December 28, 2017

Record last verified: 2017-12

Locations